An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information

NCT06193070 | Completed Results

• 4 other identifiers: RG1123830NCI-2023-0842420282P30CA015704
• Study Type: interventional
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

This clinical trial evaluates an educational escape room intervention for improving awareness of and concern about breast cancer misinformation and reducing vulnerability to believing cancer misinformation among patients with stage I-III breast cancer. Misinformation, or communication about health information that is inaccurate or false, can have serious health consequences for those that believe it. The rise of the access to and use of various sources of information on the internet such as websites and social media has caused the spread of misinformation and disinformation to grow rapidly, resulting in negative consequences on health outcomes. Cancer misinformation, in particular, has become an increasingly prevalent issue that poses a real threat to the many cancer patients in the United States. The educational escape room intervention is a game designed to teach participants how to discern whether cancer nutrition information is accurate or may potentially be misinformation. Participants are immersed in the narrative while solving puzzles to learn key themes such as the need to talk to their doctors, looking for scientific studies, as well as avoiding fads and trends, miracle cures, anecdotal evidence, and targeted and clickbait ads.

Conditions

Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8

Outcome Measures

Primary Outcomes (5)

• Percentage of Participants Accrued to the Study (Feasibility)

  The percentage of patients who accrue to the study among those who are eligible and approached.

  At enrollment

• Percentage of Patients Who Complete Game Sessions (Feasibility)

  The percentage of patients who complete the game.

  Up to 1 week

• Satisfaction (Acceptability)

  Will be assessed using a Likert-type question to assess satisfaction with the game (1 = not at all satisfied, 10 = very satisfied)

  Up to 1 week

• Likelihood to Recommend the Game to Someone Else (Acceptability)

  Will be assessed using a Likert-type question to assess likelihood to recommend the game to someone else (1 = not at all likely, 5 = very likely).

  Up to 1 week

• Usability (System Usability Scale)

  Usability will be assessed using the System Usability Scale (SUS). The SUS is a reliable, 10-item measure 10-item scale, scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree), with previously reported excellent internal reliability (Cronbach's α = 0.91). Total scores on the SUS range from 0-100, with higher scores indicating greater usability.

  Up to 1 week

Secondary Outcomes (3)

• Types of Online Information

  At baseline

• Concern About Misinformation and Confidence in Identifying Misinformation

  Up to 1 week

• Cancer Nutrition Information Beliefs

  At baseline and up to 1 week

Study Arms (1)

Supportive Care (escape room game)

EXPERIMENTAL

Patients play the virtual misinformation escape room game consisting of 5 puzzles and a final task over 30-45 minutes on study.

Other: Educational Intervention; Other: Interview; Other: Survey Administration; Other: Telemedicine

Interventions

Educational Intervention OTHER

Play virtual misinformation escape room game

Also known as: Escape room cancer nutrition game

Supportive Care (escape room game)

Interview OTHER

Ancillary studies

Supportive Care (escape room game)

Survey Administration OTHER

Ancillary studies

Supportive Care (escape room game)

Telemedicine OTHER

Play virtual misinformation escape room game

Also known as: Telehealth

Supportive Care (escape room game)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 18 years of age or older
• English speaking
• Able to provide informed consent
• Have access to a computer (desktop or laptop)
• Have been previously diagnosed with breast cancer (Stages I-III) and currently in active treatment for breast cancer

Sponsors & Collaborators

• Fred Hutchinson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

Location

MeSH Terms

Interventions

Early Intervention, Educational; Interviews as Topic; Telemedicine

Intervention Hierarchy (Ancestors)

Child Health Services; Community Health Services; Health Services; Health Care Facilities Workforce and Services; Preventive Health Services; Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Delivery of Health Care; Patient Care Management; Health Services Administration

Results Point of Contact

• Title: Dr. Megan Shen, Associate Professor
• Organization: Fred Hutchinson Cancer Center

mshen2@fredhutch.org

206-667-4172

Study Officials

• Megan Shen

  Fred Hutch/University of Washington Cancer Consortium

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: December 12, 2023
• First Posted: January 5, 2024
• Study Start: March 7, 2024
• Primary Completion: June 22, 2024
• Study Completion: June 22, 2024
• Last Updated: December 27, 2024
• Results First Posted: December 27, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)